Refine by
Laboratory Supply Articles & Analysis
14 news found
With a strong foundation in PEG technology and state-of-the-art CDMO facilities, the company offers a seamless transition from R&D laboratory supply to commercial-scale production. Key Product Highlights: · PEG Derivatives o A vast inventory of over 3000 high-quality PEG derivatives. o Monodispersed PEG linkers and multi-arm PEGs. o Scalable ...
Changsha, China – Hunan Huateng Pharmaceutical Co., Ltd. is proud to provide high-quality monodispersed polyethylene glycols (PEGs) tailored for the evolving needs of antibody-drug conjugates (ADCs). With the ADC market surpassing $10 billion in 2023 and projected to reach $13.13 billion by 2030, our commitment to innovation and quality is stronger than ever. Among the 15 approved ADCs ...
Huateng Pharma, a global leader in PEG derivatives and a premier CDMO for APIs and intermediates, is excited to announce the launch of its latest product, Y-Shape PEG NHS. This cutting-edge Succinimidyl Carboxymethyl Ester branched 2ARM PEG offers a revolutionary approach to amine PEGylation, enhancing the modification of proteins and other biologics. PEGylation, the technique of attaching a PEG ...
Dave Kunelius, President of MedSource Labs, recently addressed the Honorable Katherine Tai, United States Trade Representative, as part of an ongoing dialogue with local and national policymakers concerning challenges in the medical supply chain. In his communication dated April 19, 2024, Kunelius emphasized MedSource Labs’ role in manufacturing essential medical devices, such as IV ...
Huateng Pharma proudly announces the launch of a groundbreaking suite of anti-diabetes intermediates, featuring key compounds such as Canagliflozin, Dapagliflozin, Empagliflozin, and Semaglutide. Emphasizing the potential impact on diabetes drug development, Huateng Pharma's Research and Development Director expressed enthusiasm, stating, "Our new line of anti-diabetes intermediates represents a ...
The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies, bringing the audience and customers a better understanding of how BOC Sciences has contributed to the ADC industry. The newest report on ADC tech released by BOC Sciences officials has attracted much attention from the ...
Ended the Year With $55 Million in Cash Expected To Fund Operations Through the End of 2024 Including Release of Topline Pivotal Trial Data Nine (9) VenoValve Surgeries Successfully Completed and 16 Clinical Sites Currently Active in Ongoing SAVVE U.S Pivotal Trial Continued Advancement in Development of Second Device for the Treatment of Venous Disease Expected To Be Unveiled in Mid-2022 ...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter and full year ended December 31, 2021. Recent Highlights & Accomplishments: Received approval from the Food and Drug ...
Al Zahrawi Medical is a healthcare focused company specializing in medical, surgical, diagnostic and analytical lab, and nuclear medicine supplies with a presence throughout the region. Al Zahrawi provides top quality products, services, and support to customers in the medical and laboratory industries that create rewarding customer experiences that build long ...
StemBioSys products are available from leading laboratory supply distributors. ...
During this pandemic situation, erratic supply of lab wares and reagents, as well as bottlenecks created due to high demand and short supply of the test reagents, has created a delay in getting the population tested for COVID-19. Worldwide calls for widespread testing has skyrocketed the amount of requests for PCR reagent supply. Current ...
During this pandemic situation, erratic supply of lab wares and reagents, as well as bottlenecks created due to high demand and short supply of the test reagents, has created a delay in getting the population tested for COVID-19. Worldwide calls for widespread testing have skyrocketed the amount of requests for PCR reagent supply. Current ...
ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases announced today that it has received a significant order for its ReShape® Integrated Dual Balloon System from Al Zahrawi Medical a healthcare focused company specializing in medical, surgical, diagnostic and analytical lab and nuclear medicine supplies with ...
Camlab Ltd, the laboratory supplies company based at Over, Cambridge, today received a Royal visitor HRH the Duke of Kent. ...